...and drug-resistant melanoma. In 2016, she and Sarah Teichmann, head of cellular genetics at the Wellcome Trust Sanger Institute...

...a company employing this approach - Congenica Ltd. (Cambridge, U.K.). Based on research from the Wellcome Trust Sanger Institute...

...lines. DepMap pools data from Broad’s Project Achilles; the Broad-Novartis Cancer Cell Line Encyclopedia; the Wellcome Trust Sanger Institute's...

...lines. DepMap pools data from Broad’s Project Achilles; the Broad-Novartis Cancer Cell Line Encyclopedia; the Wellcome Trust Sanger Institute's...

...E. et al. Nat. Genet. ; published online Mar. 19, 2018 doi:10.1038/s41588-018-0079-y CONTACT: Eleftheria Zeggini, Wellcome Trust Sanger Institute...

...Location Founded Raised ($M) Partners Partnership scope Therapy type Microbiotica Ltd. Cambridge, U.K. 2016 $10 Wellcome Trust Sanger Institute...

...was spun out of the labs of co-founders Trevor Lawley and Gordon Dougan at the Wellcome Trust Sanger Institute...
...Clinical status: Preclinical Founded: 2016 by Trevor Lawley, Gordon Dougan and Mike Romanos University collaborators: Wellcome Trust Sanger Institute...
...Institutes of Health (NIH), Bethesda, Md. Nestlé S.A., Vevey, Switzerland Seres Therapeutics Inc., Cambridge, Mass. Wellcome Trust Sanger Institute...

...Bone cancer Lysosomal trafficking regulator (LYST) Truncating mutations in LYST could help diagnose sporadic chordoma. Wellcome Trust Sanger Institute...

...et al. Nat. Commun. ; published online Oct. 12, 2017 doi:10.1038/s41467-017-01026-0 CONTACT: Peter J. Campbell, Wellcome Trust Sanger Institute...

...2017 doi:10.1038/nature24678 CONTACT: Tony Kouzarides, University of Cambridge, Cambridge, U.K. email: t.kouzarides@gurdon.cam.ac.uk CONTACT: George Vassiliou, Wellcome Trust Sanger Institute...